Drug turns patients into gambling addicts

Sep 18, 2006

Scottish researchers have found that drugs used to treat Parkinson's disease appear to turn some patients into gambling addicts.

A survey of patients in western Scotland found that about 10 percent of those taking dopamine agents had become problem gamblers, The Scotsman reported. A research team from Southern General Hospital in Glasgow tracked 251 Parkinson's patients who were taking different drug combinations.

Many of the patients who became addicted were already regular bettors before they went on Parkinson's medication. But the increase was often dramatic, like the patient who went from spending 10 pounds a week gambling to 1,500 pounds a week.

Parkinson's patients appear to suffer from low levels of dopamine. Dopamine plays a role in addiction by helping the brain to recognize sources of pleasure.

Robert Brown, a Glasgow psychologist, said that what patients using dopamine are likely to turn to depends on what they have access to.

"There is a tradition of gambling across the whole of Scotland, with more gamblers per head of population than in England and Wales," Brown said. "But people on these drugs could equally turn to alcohol or other ways of finding arousal or escape."

Copyright 2006 by United Press International

Explore further: Merck ends development of Parkinson's disease drug

add to favorites email to friend print save as pdf

Related Stories

Parkinson's patients' 'risky behavior' explained

Jun 23, 2010

Scientists at UCL (University College London) have explained Parkinson's patients' risky behaviour, a rare side effect of standard treatments for the disease. The finding has implications for future medication of patients.

Recommended for you

J&J expects 10-plus new drug applications by 2017

15 hours ago

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Glaxo, US partnering to develop new antibiotics

May 22, 2013

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

User comments : 0

More news stories

Study: No higher cancer rate at Conn. Pratt plant

(AP)—Researchers examining the incidence of brain cancer at jet engine manufacturer Pratt & Whitney in Connecticut say they have found no statistically significant elevations in the rate of cancer among workers.

Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

Hormone replacement therapy—clarity at last

The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...

The long road to the 2000-watt society

The vision of a society in which each inhabitant of the earth manages to consume only 2000 watts has already been around for 15 years. During this time, there has been a steady increase in environmental awareness ...